I need to see the full pipeline landscape.

My ROI? The right deal at the right time — in less time.

"When my company turned to me for opportunities in a new therapy class, I turned to Thomson Reuters Pharma™."

Chris knew it was important to have a broad base of knowledge — especially when researching the pipelines, partnerships, and the promise of a narrow therapy area. He needed quick, easy access to accurate, up-to-the-minute information on early stage compounds, their place in the market, and the companies and deals making headway in that particular area so he could confidently recommend the best fit for his company.

This process can often take weeks, but with Thomson Reuters Pharma, Chris was able to:

  • View all drugs in development by therapy area, target/MOA, and stage of development
  • View company profiles — areas of focus, financial state, drug pipeline, listing of partnerships, and drug licensing deals
  • Search for patents by therapy area and target
  • View drug licensing deals, searchable by therapy area, stage of deal, and announced deal structures
  • View forecasts on similar drugs, combining both consensus and patient-based forecasts

This critical market information from Thomson Reuters Pharma provided the summaries, commentaries, and analysis Chris needed — all prepared by industry experts  at Thomson Reuters.

Pipeline. Deals. Companies. All from a single comprehensive source trusted by 100 PERCENT of the top 20 pharmaceutical companies. Now that's a smart investment.

Get More Information — WATCH OUR DEMO and get free report

Now you've seen what Thomson Reuters Pharma did for Chris, why not see some more of what Thomson Reuters Pharma can do for you and your business.

Simply fill out the form below in order to see a recorded video demonstration of Thomson Reuters Pharma. We'll also give you a new complimentary therapy area report, focusing on key market players and deals highlights in the Obesity area.

View a demo and download complimentary report